Article · 28 Dec 2025
ArticlePublished 28 Aug 2023
Evaluating the Efficacy and Safety of Novel Therapeutic in Phase 3 Clinical Trial
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Phase 3 clinical trials are a critical and pivotal stage in the drug development process, aimed at evaluating the safety and efficacy of a new medical intervention in a large and diverse patient population. These trials follow the successful completion of Phase 1 and Phase 2 studies, which assessed the investigational product’s safety profile, dosage range, and initial efficacy. Phase 3 trials are designed to provide substantial evidence to support the regulatory approval of the new drug or medical intervention and are considered the last step before potential market release.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Annals of Clinical Trials and Vaccines Research.
Article · 21 Mar 2025
Revolutionizing Tomorrow: The Unprecedented Journey of Biotechnology
Article · 28 Dec 2024
Quality Control in Vaccine Development: Ensuring Safety and Efficacy
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAnnals of Clinical Trials and Vaccines Research
- SubjectPharmaceutical Sciences
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Angelica Merlot”